A rating of 80 puts INmune Bio Inc (INMB) near the top of the Biotechnology industry according to InvestorsObserver. INmune Bio Inc's score of 80 means it scores higher than 80% of stocks in the industry. INmune Bio Inc also received an overall rating of 64, putting it above 64% of all stocks. Biotechnology is ranked 36 out of the 148 industries.
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 64 means the stock is more attractive than 64 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.
INmune Bio Inc (INMB) stock is trading at $26.95 as of 10:09 AM on Tuesday, Jan 19, an increase of $2.13, or 8.58% from the previous closing price of $24.82. The stock has traded between $25.08 and $28.19 so far today. Volume today is low. So far 58,396 shares have traded compared to average volume of 246,327 shares.
Click Here to get the full Stock Score Report on INmune Bio Inc (INMB) Stock.
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
You May Also Like
Continue reading here:
Is INmune Bio Inc (INMB) a Winner in the Biotechnology Industry? - InvestorsObserver
Recommendation and review posted by G. Smith
